Skip to Content
Merck
All Photos(1)

Key Documents

11684809910

Roche

In Situ Cell Death Detection Kit, AP

sufficient for ≤50 tests, kit of 1 (3 components), suitable for detection

Synonym(s):

cell death kit

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
12352200

usage

sufficient for ≤50 tests

Quality Level

packaging

kit of 1 (3 components)

manufacturer/tradename

Roche

technique(s)

immunohistochemistry: suitable

application(s)

detection

storage temp.

−20°C

Related Categories

General description

Kit for the detection and quantification of apoptotic cell death on a single-cell level by light microscopy in  immunohistocytochemistry.

Contents:
  • Enzyme Solution (TdT)
  • Label Solution (fluorescein-dUTP)
  • Converter AP (anti-fluorescein antibody-AP), ready-to-use

Specificity

The TUNEL reaction preferentially labels DNA strand breaks generated during apoptosis. This allows discrimination of apoptosis from necrosis and from primary DNA strand breaks induced by cytostatic drugs or irradiation.

Application

The In Situ Cell Death Detection Kit, AP,  is a precise, fast, and simple nonradioactive technique to detect and quantify apoptotic cell death at the single-cell level in cells and tissues by light microscopy; it is not intended for diagnostic procedures. Thus, the In Situ Cell Death Detection Kit can be used in many different assay systems. Examples are:
  • Detection of individual apoptotic cells in frozen and formalin-fixed tissue sections in basic research†
  • Determination of sensitivity of malignant cells to drug-induced apoptosis in cancer research
  • Typing of cells undergoing cell death in heterogeneous populations by double staining procedures

Features and Benefits

  • Sensitive: The maximum intensity of labeling (cell staining) of apoptotic cells is higher than the nick translation method
  • Fast: The use of fluorescein-dUTP allows analysis of the samples directly after the TUNEL reaction, but before the addition of the secondary detection system
  • Convenient: The direct labeling procedure using fluorescein-dUTP allows verification of the efficiency of the TUNEL reaction during the assay procedure
  • Accurate: Identification of apoptosis at a molecular level (DNA-strand breaks) and identification of cells at the very early stages of apoptosis
  • Flexible: No substrate included; provides the opportunity to select the staining procedure of choice

Packaging

1 kit containing 3 components.

Specifications

Widely used methods to determine apoptosis include the analysis of the genomic DNA by agarose-gel electrophoresis and DNA fragmentation assays based on 3H-thymidine and, alternatively, 5-Bromo-2′-deoxy-uridine. The methods involve the separation of fragmented, low molecular-weight DNA from unfragmented, high molecular-weight DNA in a given cell population. Thus, these methods do not provide information about the fate of an individual cell in a given cell population or, particularly, in tissue sections. Alternatively, individual apoptotic cells may be microscopically recognized because of the characteristic appearance of nuclear chromatin condensation and fragmentation, but this method is subjective and limited to a relatively narrow time window when the morphological changes are at a maximum.
The hallmark of apoptosis is DNA degradation, which in early stages is selective to the internucleosomal DNA linker regions. The DNA cleavage may yield double-stranded and single-stranded DNA breaks (nicks). Both types of breaks can be detected by labeling the free 3′-OH termini with modified nucleotides (e.g., biotin-dUTP, DIG-dUTP, fluorescein-dUTP) in an enzymatic reaction. The enzyme terminal deoxynucleotidyl transferase (TdT) catalyzes the template-independent polymerization of deoxyribonucleotides to the 3′-end of single- and double-stranded DNA. This method has also been termed TUNEL (TdT-mediated dUTP-X nick end labeling). Alternatively, free 3′-OH groups may be labeled using DNA polymerases by the template-dependent mechanism called nick translation. However, the TUNEL method is considered to be more sensitive and faster.

Sample material: Cytospin and cell smear preparations, adherent cells grown on slides, and frozen and paraffin-embedded tissue sections.

Principle

The In Situ Cell Death Detection Kit, AP is based on the detection of single- and double-stranded DNA breaks that occur at the early stages of apoptosis.
Apoptotic cells are fixed and permeabilized. Subsequently, the cells are incubated with the TUNEL reaction mixture that contains TdT and fluorescein-dUTP. During this incubation period, TdT catalyzes the addition of fluorescein-dUTP at free 3′-OH groups in single- and double-stranded DNA. After washing, the label incorporated at the damaged sites of the DNA is marked by an anti-fluorescein antibody conjugated with the reporter enzyme alkaline phosphatase. After washing to remove unbound enzyme conjugate, the AP retained in the immune complex is visualized by a substrate reaction.

Preparation Note

Working solution: Add total volume (50 μl) of Enzyme Solution to the remaining 450 μl Label Solution to obtain 500 μl TUNEL reaction mixture.
Mix well to equilibrate components.
Storage conditions (working solution): TUNEL reaction mixture
The TUNEL reaction mixture should be prepared immediately before use and should not be stored. Keep TUNEL reaction mixture on ice until use.

Converter-AP
Once thawed the Converter-AP solution should be stored at 2 to 8 °C (maximum stability
6 months).
Note: Do not freeze.

Other Notes

For life science research only. Not for use in diagnostic procedures.

Kit Components Only

Product No.
Description

  • Enzyme Solution (TdT)

  • Label Solution (fluorescein-dUTP)

  • Converter AP (anti-fluorescein antibody-AP) ready-to-use

Signal Word

Danger

Hazard Statements

Hazard Classifications

Aquatic Chronic 2 - Carc. 1B Inhalation - Skin Sens. 1

Storage Class Code

6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects

WGK

WGK 3

Flash Point(F)

does not flash

Flash Point(C)

does not flash


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Amanda R Duselis et al.
Biology of reproduction, 83(6), 988-996 (2010-08-13)
Crosses between the North American deer mouse species Peromyscus maniculatus (BW) and P. polionotus (PO) produce dramatic asymmetric developmental effects. BW females mated to PO males (female bw × male po) produce viable growth-retarded offspring. In contrast, PO females mated
Caiwei Qiu et al.
Neural regeneration research, 8(23), 2126-2133 (2014-09-11)
Sevoflurane preconditioning has neuroprotective effects in the cerebral ischemia/reperfusion model. However, its influence on permanent cerebral ischemia remains unclear. In the present study, the rats were exposed to sevoflurane for 15, 30, 60, and 120 minutes, followed by induction of
Dong Yin et al.
PloS one, 7(8), e43891-e43891 (2012-09-01)
Nanosecond pulsed electric fields (nsPEF) induce apoptotic pathways in human cancer cells. The potential therapeutic effective of nsPEF has been reported in cell lines and in xenograft animal tumor model. The present study investigated the ability of nsPEF to cause
Xiaolin Li et al.
Scientific reports, 4, 6434-6434 (2014-09-23)
Di-(2-ethylhexyl)-phthalate (DEHP) is a ubiquitously used endocrine disruptor.There is widespread exposure to DEHP in the general population which has raised substantial public concern due to its potential detrimental health effects. It is particularly pertinent to investigate the molecular mechanisms of
Marina Sirota et al.
Science translational medicine, 3(96), 96ra77-96ra77 (2011-08-19)
The application of established drug compounds to new therapeutic indications, known as drug repositioning, offers several advantages over traditional drug development, including reduced development costs and shorter paths to approval. Recent approaches to drug repositioning use high-throughput experimental approaches to

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service